ATE267249T1 - Aus dem epidermis isolierte polypeptide und verwendung davon - Google Patents

Aus dem epidermis isolierte polypeptide und verwendung davon

Info

Publication number
ATE267249T1
ATE267249T1 AT98402037T AT98402037T ATE267249T1 AT E267249 T1 ATE267249 T1 AT E267249T1 AT 98402037 T AT98402037 T AT 98402037T AT 98402037 T AT98402037 T AT 98402037T AT E267249 T1 ATE267249 T1 AT E267249T1
Authority
AT
Austria
Prior art keywords
epidermis
polypeptides isolated
intercorneocytary
favours
cathepsin
Prior art date
Application number
AT98402037T
Other languages
English (en)
Inventor
Dominique Bernard
Michel Kermici
Marie-Alix Bernard-Bourboulon
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE267249T1 publication Critical patent/ATE267249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98402037T 1997-08-29 1998-08-11 Aus dem epidermis isolierte polypeptide und verwendung davon ATE267249T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710818A FR2767833B1 (fr) 1997-08-29 1997-08-29 Polypeptide isole de l'epiderme et son utilisation

Publications (1)

Publication Number Publication Date
ATE267249T1 true ATE267249T1 (de) 2004-06-15

Family

ID=9510611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98402037T ATE267249T1 (de) 1997-08-29 1998-08-11 Aus dem epidermis isolierte polypeptide und verwendung davon

Country Status (9)

Country Link
US (2) US6274364B1 (de)
EP (1) EP0899330B1 (de)
JP (1) JP3819603B2 (de)
AT (1) ATE267249T1 (de)
CA (1) CA2243633C (de)
DE (1) DE69823935T2 (de)
DK (1) DK0899330T3 (de)
ES (1) ES2221133T3 (de)
FR (1) FR2767833B1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation
US6852686B2 (en) * 1999-06-23 2005-02-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for ameliorating icthyosiform skin diseases
DE19945486A1 (de) * 1999-09-22 2001-03-29 Henkel Kgaa Verfahren zur Färbung von keratinischen Fasern
DE19945487A1 (de) * 1999-09-22 2001-03-29 Henkel Kgaa Verfahren zur Restrukturierung keratinischer Fasern
DE10050274A1 (de) * 2000-10-09 2002-04-18 Henkel Kgaa Verfahren zur in vitro Bestimmung der Hautalterung
FR2816838B1 (fr) * 2000-11-17 2004-12-03 Oreal Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
FR2842209B1 (fr) 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
FR2846148A1 (fr) 2002-10-17 2004-04-23 Thomson Licensing Sa Encapsulation des panneaux oled a emission vers le haut
FR2888494B1 (fr) * 2005-07-13 2014-03-14 Oreal Utilisation de composes d'uree pour favoriser la desquamation
CA2619479C (en) * 2005-08-26 2012-01-03 Elc Management Llc Cosmetic composition containing a protease activator
US20080050331A1 (en) * 2006-08-23 2008-02-28 Paolo Giacomoni Cosmetic Composition Containing A Protease Activator
FR2914189A1 (fr) 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
FR2918269B1 (fr) 2007-07-06 2016-11-25 Oreal Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses.
FR2918561B1 (fr) 2007-07-09 2009-10-09 Oreal Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage.
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
FR2939036B1 (fr) 2008-12-01 2010-12-17 Oreal Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition
SG173787A1 (en) 2009-04-02 2011-09-29 Colgate Palmolive Co Exfoliating dentifrice composition and method of use
FR2946845B1 (fr) 2009-06-18 2011-08-19 Oreal Dispositif de traitement des matieres keratiniques humaines
FR2954140A1 (fr) 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
EP2512416A2 (de) 2009-12-18 2012-10-24 L'Oréal Kosmetisches behandlungsverfahren mit einer in-situ kondensierbaren verbindung
FR2956582B1 (fr) 2010-02-19 2012-08-24 Oreal Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
FR2968569B1 (fr) 2010-12-13 2013-01-04 Oreal Procede de traitement de la peau grasse non acneique.
FR3133014B1 (fr) 2022-02-28 2025-03-14 Oreal Compositions et procédés pour améliorer l’aspect de la peau
FR3134006A1 (fr) 2022-04-01 2023-10-06 L'oreal compositions et procédés pour améliorer l’aspect de la peau
CN119997929A (zh) 2022-08-31 2025-05-13 欧莱雅 用于皮肤的组合物和方法
FR3143355A1 (fr) 2022-12-14 2024-06-21 L'oreal Compositions et procédés de prévention et/ou de traitement des cicatrices
WO2025096817A1 (en) 2023-10-31 2025-05-08 L'oreal Compositions and methods for treating skin
FR3160551A3 (fr) 2024-03-26 2025-10-03 L'oreal Compositions et procédés de traitement de la peau

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710014A (en) * 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
JPH06192124A (ja) * 1992-12-25 1994-07-12 Toray Ind Inc 血液細胞増加剤
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
GB2306961B (en) * 1995-11-04 1998-06-10 Zeneca Ltd Cathepsin L at high specific actvity and recombinant manufacture thereof
DE19619366A1 (de) 1996-05-14 1997-11-20 Hoechst Ag Cathepsin-L, dessen Präpoform und das entsprechende Propeptid aus Ciliaten
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation

Also Published As

Publication number Publication date
FR2767833B1 (fr) 2001-03-02
EP0899330B1 (de) 2004-05-19
JP3819603B2 (ja) 2006-09-13
US6274364B1 (en) 2001-08-14
DE69823935D1 (de) 2004-06-24
ES2221133T3 (es) 2004-12-16
CA2243633A1 (fr) 1999-02-28
FR2767833A1 (fr) 1999-03-05
JPH11139933A (ja) 1999-05-25
US20020006654A1 (en) 2002-01-17
DK0899330T3 (da) 2004-06-28
CA2243633C (fr) 2008-06-03
EP0899330A1 (de) 1999-03-03
DE69823935T2 (de) 2005-05-25
US6737055B2 (en) 2004-05-18

Similar Documents

Publication Publication Date Title
DE69823935D1 (de) Aus dem Epidermis isolierte Polypeptide und Verwendung davon
DE69912870D1 (de) Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein
DE69108256D1 (de) Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
BR9714064A (pt) Composição farmacêutica
BR9704843B1 (pt) hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
CR5743A (es) Antitranspirante en barra con caracteristicas mejoradas
WO1996017924A3 (en) Novel hedgehog-derived polypeptides
BR0115665A (pt) Composição de tratamento das queratìnicas, uso de uma composição, processo de tratamento das matérias queratìnicas e uso de pelo menos um poliuretano associativo catiÈnico
DE60038860D1 (de) Kosmetische zusammenzetzungen enthaltend fluoreszente aufheller
BR0215576A (pt) Composição cosmética ou de cuidado pessoal, processos para a produção da mesma, método de tratamento dos cabelos e uso de partìculas gelificadas
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
DE69527052D1 (de) Verwendung von Wasser mit verringertem Deuterium-Gehalt zur Herstellung von hygienischen und kosmetischen Präparaten
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
FR2822375B1 (fr) Composition contenant des fibres, et ses utilisations notamment cosmetiques
DK1089704T3 (da) Hårplejelotion til topisk anvendelse
ATE465782T1 (de) Zusammensetzung zur behandlung von keratinfasern, die ein kationisches polyvinyllactam enthalten sowie ein konditioniermittel
BR0115990A (pt) Preparações cosméticas e/ou dermofarmacêutica contendo proteìnas nativas da planta argania spinosa
DE60133005D1 (de) Haltbare kosmetische zusammensetzung, die ein bestimmtes haftungsförderndes material enthält
AR009763A1 (es) Utilizacion en una composicion como estimulador de tirosinasa de al menos un derivado de 3-oxido pirimidina, sustituido en la posicin 6
DE69805435D1 (de) Verwendung eines diphenyldimethicongummis gelösst in einem nichtflüchtigen silikon des phenyltrimethicontyps zur herstellung von einem kosmetischen oder pharmazeutischen , insbesondere dermatologischen zusammensetzung die eine fettphase enthält
DE69803200D1 (de) Verwendung von mindestens einen chrysanthemum gattungs extrakten zur förderung der haut- und/oder der haarepigmentierung
BR0204389A (pt) Composição cosmética para tratamento dos cabelos, processo cosmético para tratamento dos cabelos, e, uso de uma composição
ATE361009T1 (de) Persönliches pflegeprodukt
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0899330

Country of ref document: EP

REN Ceased due to non-payment of the annual fee